The expression of cytokine genes in the peritoneal macrophages and splenic CD4- and CD8-positive lymphocytes of the nonobese diabetic mice

Journal of Clinical Immunology

Volumn 24, Issue 2, 2004, Pages 177-184

  Yaacob, Nik Soriani ^a   Kaderi, Mohd Arifin ^a   Norazmi, Mohd Nor ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Cytokines; Multiplex PCR; NOD mouse strain; Type 1 diabetes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SPLEEN CELL;

AGE FACTORS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED NOD; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN;

EID: 1842607717     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOCI.0000019783.61674.1d     Document Type: Article

References (45)

1. Zipris D, Mordes JP, Greiner DL, Rossini AA: Animal model of type 1 diabetes: Concordances, discordances, lessons. In Diabetes in the New Millennium, U Di Mario, PG Leonettif, P Sbraccia, A Signore (eds). West Sussex, England, Wiley, 2000, pp 1-16
2. Kawasaki E, Yamaguchi Y, Nagataki S: Insulitis in an autoimmune-mediated patient originally classified as having type 2 diabetes. Diabetes Care 22:541-542, 1999
3. Bach JF: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev 15:516-542, 1994
4. Singh B, Rabinovitch A: Influence of microbial agents on the development and prevention of autoimmune diabetes. Autoimmunity 15:209-213, 1993
5. Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by imrnunostimulation? Diabetes 43:613-621, 1994
6. Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P: IL-1α, IL-1β and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes. J Clin Invest 105:459-468, 2000
7. Grewal IS, Grewal KD, Wong SW, Wang H: Expression of transgene encoded TGF-β in islets prevents autoimmnue diabetes in NOD mice by a local mechanism. J Autoimmun 19:9-22, 2002
8. Rabinovitch A, Pinzon LS: Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 35:1139-1149, 1998
9. Ward LD, Howlett GJ, Discolo G, Yasukawa K, Hammacher A, Moritz RL, Simpson RJ: High affinity inlerleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem 269:23286-23289, 1994
10. Meagher C, Sharif S, Hussain S, Cameron MJ, Arreaza GA, Delovitch TL: Cytokines and chemokines in the pathogenesis of murine type I diabetes mellitus. In Cytokines and Chemokines in Autoimmune Disease, P Santamaria (ed). Georgetown, TX, Landes Bioscience, 2002 pp. 133-158.
11. McDuffie M: Genetics of autoimmune diabetes in animal models. Curr Opin Immunol 10:704-709, 1998
12. Kikutani H, Makino S: The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51:285-322, 1992
13. Delovitch TL, Singh B: The non-obese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity 7:727-738, 1997
14. Prochazka M, Serreze DV, Frankel WN, Leiter EH: NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41:98-106, 1992
15. Gazda LS, Charlton B, Lafferty KJ: Diabetes results from a late change in the autoimmune response of NOD mice. J Autoimmun 10:261-270, 1997
16. Rocha MF, Maia ME, Bezerra LR, Lyerly DM, Guerrant RL, Ribeiro RA, Lima AA: Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: Role of interleufcin-1 beta, tumor necrosis factor alpha, and leukotrienes. Infect Immun 65:2740-2746, 1997
17. Coligan JE, Kruisbeek AM, Marguiles DH, Shevach EM, Strobber W: Current Protocols in Immunology. New York, Greene Publishing Associates & Wiley-Intersciences. chapter 3, 1991
18. Gerring SJ, Gibbs L, Clark AJL, Flower RJ, Perretri M: POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162:7446-7453, 1999
19. Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA: Potenlial role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 160:2684-2691, 1998
20. Yoon JW, Jun HS, Santamaria P: Cellular and molecular mechanisins for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 27:109-122, 1998
21. Mandroup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
22. Heitmeir MR, Scarim AL, Corbett JA: Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin I. J Biol Chem 272:13697-13704, 1997
23. Dower SK, Kronheim SR, Hopp TP, Cantrell M, Deeley M, Gillis S, Henney CS, Utdal DL: The cell surface receptors for the interleukin-1α and interleukin-1β are identical. Nature 324:266-267, 1986
24. Dicosmo BF, Picarella D, Flavell RA: Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in nonobese diabetic mice. Int Immunol 6:1829-1837, 1994
25. Rincón M, Anguita J, Nakamura T, Fikrig E, Flavell RA: Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 185:461-470, 1997
26. Nakata K, Akagawa KS, Fukayama M, Hayashi Y, Kadokura M, Tokunaga T: Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro. J Immunol 147:1266-1272, 1991
27. Holden RJ, Pakula IS, Mooney PA: Tumor necrosis factor-alpha: A continuum of liability between insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus and carcinoma. Med Hypotheses 52:319-323, 1999
28. Wachlin G, Augstein P, Schroder D, Kuttler B, Kloting I, Heinke P, Schmidt S: IL-1β, IFN-β and TNF-α increase vulnerability of pancreatic β cells to autoimmune destruction. J Autoimmun 20:303-312, 2003
29. Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA, Flavell RA: Local expression of transgene encoded TNF α in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J Exp Med 184:1963-1974, 1996
30. Cope AP, Liblau RS, Yang X-D, Congia M, Laudanna C, Schreiber RD, Probert L, Kollias G, McDevitt HO: Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 185:1573-1584, 1997
31. Christen U, Wolfe T, Mohrle U, Hughes AC, Rodrigo E, Green EA, Flavell RA, von Herrath MG: A dual role of TNF-α in the type-1 diabetes: Islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166:7023-7032, 2001
32. Gorelik L, Flavell RA: Abrogation of TGF-beta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171-181, 2000
33. King C, Davies J, Mueller R, Lee MS, Krahl T, Yeung B, O'Connor E, Sarvetnik N: TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 8:601-613, 1998
34. Suarez-Pinzon W, Korbutt GS, Power R, Hooton J, Rajotte RV, Rabinovitch A: Testicular sertoli cells protect islet beta cells from autoimmune destruction in NOD mice by transforming growth factor-beta 1-dependent mechanism. Diabetes 49:1810-1818, 2000
35. von Herrath MG, Oldstone MB: Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J Exp Med 185:531-539, 1997
36. Sarvetnick N, Shizuru J, Liggitt D, Martin L, McIntyre B, Gregory A, Parslow T, Stewart T: Loss of pancreatic islet tolerance induced by β cell expression of interferon γ. Nature 346:844-847, 1990
37. Nicoletti F, Meroni PL, Landolfo S, Gariglio M, Guzzardi S, Barcellini W, Lunetta M, Mughini L, Zanussi C: Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γ. Lancet 336:319, 1990
38. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, Bach JF: Prevention of diabetes in NOD mice treated with antibody to murine rIFN-γ. J Autoimmun 4:237-248, 1991
39. Hultgren B, Huang X, Dybdal N, Stewart TA: Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812-817, 1996
40. Serreze DV, Chapman HD, Post CM, Johnson EA, Suarez-Pinzon WL, Rabinovitch A: Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol 166:1352-1359, 2001
41. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739-1742, 1993
42. Savinov AY, Wong FS, Chervonsky AV: IFN-gamma affects homing of diabetogenic T cells. J Immunol 167:6637-6643, 2001
43. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL: Interleukin 4 reverses T cell proliferate unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:87-99, 1993
44. Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL: IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 159:4686-4692, 1997
45. + T and B lymphocytes. J Immunol 161:4420-4427, 1998